Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Jun;12(5):321-2.
doi: 10.1111/j.1477-2574.2010.00186.x.

Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus conference

Kelly W Burak  1 , Melanie B Thomas, Andrew X Zhu
Affiliations
Comment

Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus conference

Kelly W Burak et al. HPB (Oxford). 2010 Jun.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

References

    1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236. - PubMed
    1. Schwarz RE, Abou-Alfa GK, Geschwind JF, Krishnan S, Salem R, Venook SA. Nonoperative therapies for combined modality treatment of hepatocellular cancer: a consensus statement. HPB. 2010;12:313–320. - PMC - PubMed
    1. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–1739. - PubMed
    1. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171. - PubMed
    1. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003;37:429–442. - PubMed

MeSH terms